Companies × risks
Chemicals & pharmaceutical manufacturing
12 of the 18 Chemicals & pharmaceutical manufacturing companies we reviewed acknowledge at least one AI risk. The most common is discrimination, acknowledged by 10.
AI risks these companies acknowledge
- Discrimination: acknowledged by 10 of 18
- Transparency & interpretability: acknowledged by 6 of 18
- Loss of privacy: acknowledged by 5 of 18
- False information: acknowledged by 3 of 18
- Capability & robustness: acknowledged by 3 of 18
- Weapons & cyberattacks: acknowledged by 2 of 18
- Devaluation of human creativity: acknowledged by 2 of 18
- Unequal performance: acknowledged by 1 of 18
- Disinformation & influence: acknowledged by 1 of 18
- Overreliance & unsafe use: acknowledged by 1 of 18
- Governance failure: acknowledged by 1 of 18
- Environmental harm: acknowledged by 1 of 18
Companies we reviewed
- Novartis acknowledges 6 of 24 AI risks
- L'Oreal acknowledges 5 of 24 AI risks
- Eli Lilly acknowledges 4 of 24 AI risks
- Kenvue acknowledges 4 of 24 AI risks
- Amgen acknowledges 3 of 24 AI risks
- Johnson & Johnson acknowledges 3 of 24 AI risks
- Roche acknowledges 3 of 24 AI risks
- Alnylam Pharmaceuticals acknowledges 2 of 24 AI risks
- AstraZeneca acknowledges 2 of 24 AI risks
- Merck acknowledges 2 of 24 AI risks
- Novo Nordisk acknowledges 1 of 24 AI risks
- PPG Industries acknowledges 1 of 24 AI risks
- AbbVie acknowledges 0 of 24 AI risks
- Air Products and Chemicals acknowledges 0 of 24 AI risks
- Argenx acknowledges 0 of 24 AI risks
- Linde acknowledges 0 of 24 AI risks
- Novonesis acknowledges 0 of 24 AI risks
- Procter & Gamble acknowledges 0 of 24 AI risks